Metraipolis › archive › dc_52480df2a0bd

Antibody-based regimens targeting PD-1/PD-L1 and VEGF/VEGFR in advanced or metastatic NSCLC: a meta-analysis of RCTs — Europe PMC PMID:42344916

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42344916
DOI
10.3389/fimmu.2026.1847913
License (as archived)
solo-consultazione
Archived
2026-10-31T16:02:40.631Z
SHA-256 of the archived text
7cc310d6d78c1581ba18582b0a4a725ddf3c252eb76b2aefd2bac26c85cf8945
Stable URL of this page
https://metraipolis.com/documento/dc_52480df2a0bd

How to cite

Antibody-based regimens targeting PD-1/PD-L1 and VEGF/VEGFR in advanced or metastatic NSCLC: a meta-analysis of RCTs — Europe PMC PMID:42344916 — Europe PMC (en), https://europepmc.org/article/MED/42344916 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_52480df2a0bd (Metraipolis archive dc_52480df2a0bd, sha256 7cc310d6d78c1581ba18582b0a4a725ddf3c252eb76b2aefd2bac26c85cf8945)
BibTeX
@misc{dc52480df2a0bd,
  title = {Antibody-based regimens targeting PD-1/PD-L1 and VEGF/VEGFR in advanced or metastatic NSCLC: a meta-analysis of RCTs — Europe PMC PMID:42344916},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42344916},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_52480df2a0bd; sha256 7cc310d6d78c1581ba18582b0a4a725ddf3c252eb76b2aefd2bac26c85cf8945},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42344916. Agents can read the archived copy with the MCP tool read_document.